CMS vs ED

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

CMS

62.5
AI Score
VS
CMS Wins

ED

59.5
AI Score

Investment Advisor Scores

CMS

Oct 01, 2026
63score
Recommendation
HOLD

ED

Oct 01, 2026
60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CMS ED Winner
Forward P/E 15.2439 16.0772 CMS
PEG Ratio 2.2767 2.0608 ED
Revenue Growth -0.5% 13.2% ED
Earnings Growth -43.9% 22.1% ED
Tradestie Score 62.5/100 59.5/100 CMS
Profit Margin 11.6% 12.5% ED
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CMS 1M: -6.7% · 3M: -18.4% ED 1M: -3.8% · 3M: -9.1%

Current Technical Phase

CMS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 30

RSI (14): 30.0 · Price: $63.40

ED

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 42

RSI (14): 42.1 · Price: $103.59

Fundamentals Snapshot

Metric CMS ED
Market Cap — —
Forward P/E 15.2 15.7
Trailing P/E 18.8 17.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.2% 0.2%
EPS 3.37 6.09
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CMS is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.